STOCK TITAN
  1. Home
  2. Sec-filings
  3. VCYT
  4. [Form 4] VERACYTE, INC. Insider Trading Activity

Veracyte legal chief sells 3,254 shares under plan

EVP and General Counsel Annie McGuire sold Veracyte shares under a pre-arranged Rule 10b5-1 plan and had additional shares withheld to cover taxes on RSU vesting.

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

VERACYTE, INC. (VCYT) reports that Annie McGuire, EVP and General Counsel, disposed of common stock in several transactions. On September 4, 2026, she sold 2,154 shares at a weighted average price of $42.79 and 1,100 shares at a weighted average price of $43.67, in open-market or private transactions made under a Rule 10b5-1 plan adopted on August 29, 2025. On September 2, 2026, 3,215 shares were withheld to satisfy tax obligations upon vesting of restricted stock units, which the company states does not represent a sale.

Positive

  • None.

Negative

  • None.
Insider McGuire Annie
Role EVP, General Counsel
Sold 3,254 shs ($140K)
Type Security Shares Price Value
Sale Common Stock F3, F4 2,154 $42.7916 $92K
Sale Common Stock F3, F5 1,100 $43.6718 $48K
Tax Withholding Common Stock F1, F2 3,215 $44.88 $144K
Holdings After Transaction: Common Stock — 131,160 shares (Direct)
Footnotes (5)
  1. F1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale.
  2. F2. Includes 389 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.
  3. F3. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025.
  4. F4. Represents weighted average sales price. Sale prices for the transactions range from $42.49 to $43.38. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  5. F5. Represents weighted average sales price. Sale prices for the transactions range from $43.50 to $44.16. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Shares sold (lot 1) 2,154 shares Common stock sold on September 4, 2026 at a weighted average price of $42.79
Shares sold (lot 2) 1,100 shares Common stock sold on September 4, 2026 at a weighted average price of $43.67
Total shares sold 3,254 shares Aggregate of reported open-market or private sales on September 4, 2026
Shares withheld for taxes 3,215 shares Withheld on September 2, 2026 to satisfy tax obligations for RSU vesting
Weighted average sale price (lot 1) $42.7916 per share 2,154-share sale; prices ranged from $42.49 to $43.38
Weighted average sale price (lot 2) $43.6718 per share 1,100-share sale; prices ranged from $43.50 to $44.16
Tax-withholding price $44.88 per share Per-share price for 3,215 shares withheld for tax obligations on September 2, 2026
Rule 10b5-1 plan adoption date August 29, 2025 Date the reporting person adopted the Rule 10b5-1 trading plan covering these sales
Rule 10b5-1 plan regulatory
"transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
restricted stock units financial
"in connection with the vesting of certain restricted stock units on September 2, 2026"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted average sales price financial
"Represents weighted average sales price. Sale prices for the transactions range"

FAQ

What insider transactions did Veracyte (VCYT) report for Annie McGuire?
Veracyte reported that Annie McGuire sold 2,154 shares and 1,100 shares of common stock on September 4, 2026, and had 3,215 shares withheld on September 2, 2026 to satisfy tax obligations for vesting restricted stock units.

At what prices were the Veracyte (VCYT) shares sold by Annie McGuire?
On September 4, 2026, Annie McGuire’s sales used weighted average prices of $42.79 for 2,154 shares, with actual prices ranging from $42.49 to $43.38, and $43.67 for 1,100 shares, with prices ranging from $43.50 to $44.16.

Were Annie McGuire’s Veracyte (VCYT) share sales made under a Rule 10b5-1 plan?
Yes. The filing states that the transactions on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by Annie McGuire on August 29, 2025, and the Rule 10b5-1 checkbox is affirmed.

Did the 3,215-share Veracyte (VCYT) transaction represent an open-market sale?
No. The 3,215 shares on September 2, 2026 represent shares withheld to satisfy tax withholding obligations related to vesting restricted stock units, and the filing states this does not represent a sale.

What is Annie McGuire’s role at Veracyte (VCYT) mentioned in the Form 4?
The reporting person, Annie McGuire, is identified as an officer of Veracyte, Inc., holding the title EVP, General Counsel in the Form 4 filing.

How many Veracyte (VCYT) shares did Annie McGuire dispose of through sales versus tax withholding?
According to the Form 4 summary, she sold a total of 3,254 shares in open-market or private transactions and had 3,215 shares disposed of through withholding to satisfy tax obligations on RSU vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McGuire Annie
(Last)(First)(Middle)
6000 SHORELINE COURT, SUITE 300
(Street)
SOUTH SAN FRANCISCO CALIFORNIA 94080
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, General Counsel
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/02/2026F(1)3,215D$44.88134,414(2)D
Common Stock09/04/2026S(3)2,154D$42.7916(4)132,260D
Common Stock09/04/2026S(3)1,100D$43.6718(5)131,160D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale.
2. Includes 389 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.
3. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025.
4. Represents weighted average sales price. Sale prices for the transactions range from $42.49 to $43.38. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
5. Represents weighted average sales price. Sale prices for the transactions range from $43.50 to $44.16. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Remarks:
/s/ Jonathan Wygant, as attorney-in-fact09/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR